🇺🇸 FDA
Patent

US 8110651

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

granted A61KA61K47/59

Quick answer

US patent 8110651 (Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same) held by Serina Therapeutics, Inc. expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/59